DSTP3086S

DSTP3086S · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DSTP3086S, covering 2016-10-04 to 2016-10-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

See pricing